{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:39:06Z","timestamp":1787240346891,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-025-00224-w","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:01:22Z","timestamp":1750791682000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors related to reversal of prediabetes in patients from a cardiovascular risk program during 2019 -\u20092023"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6079-6974","authenticated-orcid":false,"given":"Wilfredo Antonio","family":"Rivera-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-209X","authenticated-orcid":false,"given":"Aura Mar\u00eda","family":"Salazar-Solarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5976-528X","authenticated-orcid":false,"given":"Diana Marcela","family":"S\u00e1nchez-Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6155-4961","authenticated-orcid":false,"given":"Lun\u00e9var Figueroa","family":"Torregrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2525-9935","authenticated-orcid":false,"given":"Robinson","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7682-7293","authenticated-orcid":false,"given":"Yesit","family":"Bola\u00f1os-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-2938","authenticated-orcid":false,"given":"Mar\u00eda Eugenia","family":"Casanova-Valderrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"issue":"16","key":"224_CR1","first-page":"85","volume":"2023","author":"Z Yan","year":"2022","unstructured":"Yan Z, Cai M, Han X, Chen Q, Lu H. The interaction between age and risk factors for diabetes and prediabetes: a community-based cross-sectional study. Diabetes Metab Syndr Obes. 2022;2023(16):85\u201393.","journal-title":"Diabetes Metab Syndr Obes."},{"key":"224_CR2","doi-asserted-by":"publisher","unstructured":"Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017;356:i6538. https:\/\/doi.org\/10.1136\/bmj.i6538.","DOI":"10.1136\/bmj.i6538"},{"issue":"7","key":"224_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2337\/dc17-2222","volume":"41","author":"KI Galaviz","year":"2018","unstructured":"Galaviz KI, Weber MB, Straus A, Haw JS, Venkat Narayan KM, Ali MK. Global diabetes prevention interventions: a systematic review and network meta-analysis of the real-world impact on incidence, weight, and glucose. Diabetes Care. 2018;41(7):1526\u201334.","journal-title":"Diabetes Care."},{"key":"224_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pcd.2018.07.003","volume":"12","author":"A Glechner","year":"2018","unstructured":"Glechner A, Keuchel L, Affengruber L, Titscher V, Sommer I, Matyas N, et al. Effects of lifestyle changes on adults with prediabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2018;12:393\u2013408. Elsevier Ltd.","journal-title":"Prim Care Diabetes."},{"issue":"6","key":"224_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dmrr.3316","volume":"36","author":"DL Dixon","year":"2020","unstructured":"Dixon DL, Carbone S. Screening, identification, and management of prediabetes to reduce cardiovascular risk: a missed opportunity? Diabetes Metab Res Rev. 2020;36(6):1\u20133.","journal-title":"Diabetes Metab Res Rev."},{"issue":"10397","key":"224_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203\u201334.","journal-title":"Lancet."},{"issue":"4","key":"224_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-8587(19)30058-0","volume":"7","author":"MI Schmidt","year":"2019","unstructured":"Schmidt MI, Bracco PA, Yudkin JS, Bensenor IM, Griep RH, Barreto SM, et al. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil. Lancet Diabetes Endocrinol. 2019;7(4):267\u201377.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"224_CR8","first-page":"1","volume":"10","author":"B Richter","year":"2018","unstructured":"Richter B, Hemmingsen B, Metzendorf MITY. Development of type 2 diabetes mellitus in people with intermediate hyperglycemia. Cochrane Database Syst Rev. 2018;10:1\u2013455.","journal-title":"Cochrane Database Syst Rev."},{"key":"224_CR9","doi-asserted-by":"crossref","unstructured":"Standards of Medical Care in Diabetes\u20142022 Abridged for Primary Care Providers. Clin Diabetes 2022;40(1):10\u201338. Available from: https:\/\/diabetesjournals.org\/clinical\/article\/40\/1\/10\/139035\/Standards-of-Medical-Care-in-Diabetes-2022.","DOI":"10.2337\/cd22-as01"},{"key":"224_CR10","first-page":"1","volume":"41","author":"P L\u00f3pez-Jaramillo","year":"2017","unstructured":"L\u00f3pez-Jaramillo P, Nieto-Mart\u00ednez RE, Aure-Fari\u00f1ez G, Mendivil CO, Lahsen RA, Silva-Filho RL, et al. Identification and management of prediabetes: results of the Latin America strategic prediabetes meeting. Rev Panam Salud Publica\/Pan Am J Public Heal. 2017;41:1\u20137.","journal-title":"Rev Panam Salud Publica\/Pan Am J Public Heal."},{"key":"224_CR11","doi-asserted-by":"publisher","unstructured":"Baranowska-Jurkun A, Matuszewski W, Bandurska-Stankiewicz E. Chronic microvascular complications in prediabetic states\u2014an overview. J Clin Med. 2020;9(10):3289. https:\/\/doi.org\/10.3390\/jcm9103289.","DOI":"10.3390\/jcm9103289"},{"issue":"4","key":"224_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.amepre.2021.10.020","volume":"62","author":"KI Galaviz","year":"2022","unstructured":"Galaviz KI, Weber MB, Suvada K, Gujral UP, Wei J, Merchant R, et al. Interventions for reversing prediabetes: a systematic review and meta-analysis. Am J Prev Med. 2022;62(4):614\u201325.","journal-title":"Am J Prev Med."},{"issue":"1","key":"224_CR13","first-page":"162","volume":"34","author":"TN England","year":"2002","unstructured":"England TN. Reduction of the incidence of type 2 diabetes with lifestyle intervention or metformin. Int Urol Nephrol. 2002;34(1):162\u20133.","journal-title":"Int Urol Nephrol."},{"issue":"2","key":"224_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jamainternmed.2020.5938","volume":"181","author":"M Sampson","year":"2021","unstructured":"Sampson M, Clark A, Bachmann M, Garner N, Irvine L, Howe A, et al. Lifestyle intervention with or without lay volunteers to prevent type 2 diabetes in people with impaired fasting glucose and\/or nondiabetic hyperglycemia: a randomized clinical trial. JAMA Intern Med. 2021;181(2):168\u201378.","journal-title":"JAMA Intern Med."},{"issue":"6","key":"224_CR15","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","volume":"2","author":"G Li","year":"2014","unstructured":"Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing diabetes prevention study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2(6):474\u201380. https:\/\/doi.org\/10.1016\/S2213-8587(14)70057-9.","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"224_CR16","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1080\/03007995.2019.1601455","volume":"35","author":"K Rett","year":"2019","unstructured":"Rett K, Gottwald-Hostalek U. Understanding prediabetes: definition, prevalence, burden and treatment options for an emerging disease. Curr Med Res Opin. 2019;35(9):1529\u201334.","journal-title":"Curr Med Res Opin."},{"key":"224_CR17","doi-asserted-by":"publisher","unstructured":"Segu\u00ed D\u00edaz M. Prevenci\u00f3n de la diabetes tipo 2 mediante la dieta mediterr\u00e1nea y grasas vegetales: El estudio PREDIMED (PREVENCI\u00d3N CON DIETA MEDITERRANEA). Semergen . 2014;40(5):278-9. https:\/\/doi.org\/10.1016\/j.semerg.2014.04.009. Epub 2014 May 29.","DOI":"10.1016\/j.semerg.2014.04.009"},{"issue":"12","key":"224_CR18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1177\/1535370216654227","volume":"241","author":"B Brannick","year":"2016","unstructured":"Brannick B, Wynn A, Dagogo-Jack S. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications. Exp Biol Med. 2016;241(12):1323\u201331.","journal-title":"Exp Biol Med."},{"issue":"2","key":"224_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.22267\/rus.222402.270","volume":"24","author":"N Buitrago-G\u00f3mez","year":"2022","unstructured":"Buitrago-G\u00f3mez N, Figueroa L, Casanova ME. La prediabetes y su impacto sobre la salud cardiovascular: art\u00edculo de revisi\u00f3n. Univ y Salud. 2022;24(2):170\u201383.","journal-title":"Univ y Salud."},{"issue":"4","key":"224_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamainternmed.2020.8774","volume":"181","author":"MR Rooney","year":"2021","unstructured":"Rooney MR, Rawlings AM, Pankow JS, Echouffo Tcheugui JB, Coresh J, Sharrett AR, et al. Risk of progression to diabetes among older adults with prediabetes. JAMA Intern Med. 2021;181(4):511\u20139.","journal-title":"JAMA Intern Med."},{"issue":"2","key":"224_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.7762\/cnr.2015.4.2.97","volume":"4","author":"SR Yoon","year":"2015","unstructured":"Yoon SR, Lee JH, Na GY, Seo YJ, Han S, Shin M-J, et al. Glycated hemoglobin is a better predictor than fasting glucose for cardiometabolic risk in non-diabetic Korean women. Clin Nutr Res. 2015;4(2):97.","journal-title":"Clin Nutr Res."},{"issue":"2","key":"224_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1464-5491.2007.02043.x","volume":"24","author":"DM Nathan","year":"2007","unstructured":"Nathan DM, Chew E, Christophi CA, Davis MD, Fowler S, Goldstein BJ, et al. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the diabetes prevention program. Diabet Med. 2007;24(2):137\u201344.","journal-title":"Diabet Med."},{"issue":"12","key":"224_CR23","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/dme.13113","volume":"33","author":"JB Echouffo-Tcheugui","year":"2016","unstructured":"Echouffo-Tcheugui JB, Narayan KM, Weisman D, Golden SH, Jaar BG. Association between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis. Diabet Med. 2016;33(12):1615\u201324.","journal-title":"Diabet Med."},{"key":"224_CR24","doi-asserted-by":"publisher","unstructured":"Knowler et al. The New England Journal of Medicine Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403. https:\/\/doi.org\/10.1056\/NEJMoa012512.","DOI":"10.1056\/NEJMoa012512"},{"key":"224_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fendo.2019.00455","volume":"10","author":"Z Sheng","year":"2019","unstructured":"Sheng Z, Cao JY, Pang YC, Xu HC, Chen JW, Yuan JH, et al. Effects of lifestyle modification and anti-diabetic medicine on prediabetes progress: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2019;10:455.","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"9833","key":"224_CR26","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","volume":"379","author":"L Perreault","year":"2012","unstructured":"Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the diabetes prevention program outcomes study. Lancet. 2012;379(9833):2243\u201351.","journal-title":"Lancet."},{"issue":"1","key":"224_CR27","first-page":"1","volume":"05","author":"C Gir\u00e1ldez-Garc\u00eda","year":"2014","unstructured":"Gir\u00e1ldez-Garc\u00eda C, Garc\u00eda-Soid\u00e1n FJ, Serrano Mart\u00edn R, Carrillo L, Sangr\u00f3s Gonz\u00e1lez FJ, Franch Nadal J, et al. Evoluci\u00f3n de pacientes con prediabetes en Atenci\u00f3n Primaria de Salud (PREDAPS): resultados del primer a\u00f1o de seguimiento. Diabetes Pr\u00e1ctica. 2014;05(1):1\u201348.","journal-title":"Diabetes Pr\u00e1ctica."},{"issue":"3","key":"224_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2337\/diacare.26.3.725","volume":"26","author":"J Lindstr\u00f6m","year":"2003","unstructured":"Lindstr\u00f6m J, Tuomilehto J. The diabetes risk score. Diabetes Care. 2003;26(3):725\u201331.","journal-title":"Diabetes Care."},{"issue":"2","key":"224_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.diabet.2010.09.006","volume":"37","author":"K Makrilakis","year":"2011","unstructured":"Makrilakis K, Liatis S, Grammatikou S, Perrea D, Stathi C, Tsiligros P, et al. Validation du questionnaire finlandais calculant un score de risque de diab\u00e8te (FINDRISC) pour le d\u00e9pistage du diab\u00e8te de type 2, des anomalies de la glycor\u00e9gulation et du syndrome m\u00e9tabolique en Gr\u00e8ce. Diabetes Metab. 2011;37(2):144\u201351.","journal-title":"Diabetes Metab."},{"issue":"5","key":"224_CR30","doi-asserted-by":"publisher","first-page":"e97865","DOI":"10.1371\/journal.pone.0097865","volume":"9","author":"L Zhang","year":"2014","unstructured":"Zhang L, Zhang Z, Zhang Y, Hu G, Chen L. Evaluation of Finnish diabetes risk score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999\u20132010. PLoS One. 2014;9(5):e97865.","journal-title":"PLoS One."},{"issue":"January","key":"224_CR31","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA Elsayed","year":"2023","unstructured":"Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023. Diabetes Care. 2023;46(January):S19-40.","journal-title":"Diabetes Care."},{"issue":"8","key":"224_CR32","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00125-019-4895-0","volume":"62","author":"D Vistisen","year":"2019","unstructured":"Vistisen D, Kivim\u00e4ki M, Perreault L, Hulman A, Witte DR, Brunner EJ, et al. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study. Diabetologia. 2019;62(8):1385\u201390.","journal-title":"Diabetologia."},{"issue":"1","key":"224_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):1\u201317. https:\/\/doi.org\/10.1186\/s12933-022-01511-x.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"224_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):1\u201311.","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"224_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):1\u201312. https:\/\/doi.org\/10.1186\/s12933-023-02115-9.","journal-title":"Cardiovasc Diabetol."},{"issue":"9","key":"224_CR36","doi-asserted-by":"publisher","first-page":"102605","DOI":"10.1016\/j.dsx.2022.102605","volume":"16","author":"ANV Darshan","year":"2022","unstructured":"Darshan ANV, Rajput R, Meena, Mohini, Garg R, Saini S. Comparison of triglyceride glucose index and HbA1C as a marker of prediabetes \u2013 a preliminary study. Diabetes Metab Syndr Clin Res Rev. 2022;16(9):102605.","journal-title":"Diabetes Metab Syndr Clin Res Rev."},{"issue":"1","key":"224_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-021-01438-9","volume":"21","author":"X Wang","year":"2022","unstructured":"Wang X, Xu W, Song Q, Zhao Z, Meng X, Xia C, et al. Association between the triglyceride\u2013glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):1\u201310.","journal-title":"Cardiovasc Diabetol."},{"issue":"7","key":"224_CR38","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2337\/dc09-1939","volume":"33","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W, Bullard KMK, et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care. 2010;33(7):1665\u201373.","journal-title":"Diabetes Care."},{"issue":"3","key":"224_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12030804","volume":"12","author":"OE Amer","year":"2020","unstructured":"Amer OE, Sabico S, Alfawaz HA, Aljohani N, Hussain SD, Alnaami AM, et al. Reversal of prediabetes in saudi adults: results from an 18 month lifestyle intervention. Nutrients. 2020;12(3):1\u201310.","journal-title":"Nutrients."},{"issue":"14","key":"224_CR40","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jama.2023.4063","volume":"329","author":"JB Echouffo-Tcheugui","year":"2023","unstructured":"Echouffo-Tcheugui JB, Perreault L, Ji L, Dagogo-Jack S. Diagnosis and management of prediabetes: a review. Jama. 2023;329(14):1206\u201316.","journal-title":"Jama."},{"key":"224_CR41","doi-asserted-by":"publisher","unstructured":"Acosta Ruiz LX, Merch\u00e1n MA, Orjuela Vargas L. Diabetes mellitus tipo 2: Latinoam\u00e9rica y Colombia, an\u00e1lisis del \u00faltimo quinquenio. Revista Med. 2023;31(2):35-46. https:\/\/doi.org\/10.18359\/rmed.6067. Epub April 10, 2024.","DOI":"10.18359\/rmed.6067"},{"key":"224_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.diabres.2019.05.033","volume":"153","author":"I Ezquerra-L\u00e1zaro","year":"2019","unstructured":"Ezquerra-L\u00e1zaro I, Cea-Soriano L, Giraldez-Garc\u00eda C, Ruiz A, Franch-Nadal J, Diez-Espino J, et al. Lifestyle factors do not explain the difference on diabetes progression according to type of prediabetes: results from a Spanish prospective cohort of prediabetic patients. Diabetes Res Clin Pract. 2019;153:66\u201375.","journal-title":"Diabetes Res Clin Pract."},{"issue":"2","key":"224_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/NUR.0000000000000504","volume":"34","author":"CJ Piccinini","year":"2020","unstructured":"Piccinini CJ. Development of type 2 diabetes mellitus in people with intermediate hyperglycemia. Clin Nurse Spec. 2020;34(2):48\u20139.","journal-title":"Clin Nurse Spec."},{"issue":"3","key":"224_CR44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/joim.12920","volume":"286","author":"Y Shang","year":"2019","unstructured":"Shang Y, Marseglia A, Fratiglioni L, Welmer AK, Wang R, Wang HX, et al. Natural history of prediabetes in older adults from a population-based longitudinal study. J Intern Med. 2019;286(3):326\u201340.","journal-title":"J Intern Med."},{"issue":"5","key":"224_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12051538","volume":"12","author":"M Bennasar-Veny","year":"2020","unstructured":"Bennasar-Veny M, Fresneda S, L\u00f3pez-Gonz\u00e1lez A, Busquets-Cort\u00e9s C, Aguil\u00f3 A, Ya\u00f1ez AM. Lifestyle and progression to type 2 diabetes in a cohort of workers with prediabetes. Nutrients. 2020;12(5):1\u201313.","journal-title":"Nutrients."},{"issue":"March","key":"224_CR46","first-page":"1","volume":"9","author":"ZZ Jiang","year":"2022","unstructured":"Jiang ZZ, Zhu JB, Shen HL, Zhao SS, Tang YY, Tang SQ, et al. A high triglyceride-glucose index value is associated with an increased risk of carotid plaque burden in subjects with prediabetes and new-onset type 2 diabetes: a real-world study. Front Cardiovasc Med. 2022;9(March):1\u201310.","journal-title":"Front Cardiovasc Med."},{"issue":"9","key":"224_CR47","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamacardio.2019.2499","volume":"4","author":"T Wang","year":"2019","unstructured":"Wang T, Lu J, Su Q, Chen Y, Bi Y, Mu Y, et al. Ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes. JAMA Cardiol. 2019;4(9):874\u201383.","journal-title":"JAMA Cardiol."},{"key":"224_CR48","first-page":"848","volume":"370","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang Y, Li M, Wu JHY, Mai L, Li J, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:848\u20139.","journal-title":"BMJ."},{"issue":"4","key":"224_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.25100\/cm.v48i4.3662","volume":"48","author":"P L\u00f3pez-Jaramillo","year":"2017","unstructured":"L\u00f3pez-Jaramillo P, Calder\u00f3n C, Castillo J, Escobar ID, Melgarejo E, Parra GA. Prediabetes in Colombia: expert consensus. Colomb Med. 2017;48(4):191\u2013203.","journal-title":"Colomb Med."}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00224-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-025-00224-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-025-00224-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:01:26Z","timestamp":1750791686000},"score":1,"resource":{"primary":{"URL":"https:\/\/clindiabetesendo.biomedcentral.com\/articles\/10.1186\/s40842-025-00224-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1186\/s40842-025-00224-w","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the ethics committee of DIME Neurocardiovascular\u2019s Clinic, and by Research Committee of the Universidad Libre (Act number 012 of February 23, 2023) as a research without risk according to the classification of research risk declared in Resolution 008430 of 1993 of the Colombian Ministry of Social Protection. The approval of the institutional ethics committee included approval for the use of the data and according to the guidelines of the Helsinki declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors assert that there are no undisclosed conflicts of interest (both personal and institutional) regarding specific financial interests that are relevant to the work conducted or reported in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}